| CAS ID: | 1256388-51-8 |
| Molecular Formula: | C49H54F2N8O6 |
| Molecular Weight: | 889 g/mol |
| Monoisotopic Mass: | 888.4134 g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | LEDIPASVIR | GS-5885 |
| Analysis: | Drug repositioning mechanism analysis |
| InChI: | InChI=1S/C49H54F2N8O6/c1-24(2)39(56-46(62)64-5)44(60)58-23-48(15-16-48)21-38(58)42-52-22-37(55-42)28-9-13-32-31-12-8-26(18-33(31)49(50,51)34(32)19-28)27-10-14-35-36(20-27)54-43(53-35)41-29-7-11-30(17-29)59(41)45(61)40(25(3)4)57-47(63)65-6/h8-10,12-14,18-20,22,24-25,29-30,38-41H,7,11,15-17,21,23H2,1-6H3,(H,52,55)(H,53,54)(H,56,62)(H,57,63)/t29-,30+,38-,39-,40-,41-/m0/s1 | See All |
| InChI Key: | VRTWBAAJJOHBQU-KMWAZVGDSA-N | |
| Smiles: | COC(=O)N[C@@H](C(C)C)C(=O)N1CC2(CC2)C[C@H]1c3nc(c[nH]3)c4ccc5c6ccc(cc6C(F)(F)c5c4)c7ccc8[nH]c(nc8c7)[C@@H]9[C@H]%10CC[C@H](C%10)N9C(=O)[C@@H](NC(=O)OC)C(C)C | See All |
| Molfile: | Download |
Trial Record 1
| ClinicalTrial ID | NCT02705534 | Disease | Liver fibrosis |
| Phase | Phase 3 | Status | Completed |
| First Received | March 10, 2016 | Last Verified | April 30, 2018 |
| Sponsor | Tehran University of Medical Sciences | ||
Trial Record 2
| ClinicalTrial ID | NCT02597166 | Disease | Liver fibrosis |
| Phase | Phase 3 | Status | Completed |
| First Received | November 5, 2015 | Last Verified | October 25, 2018 |
| Sponsor | University Health Network, Toronto | ||
| PubChem: | 67505836 |
| ChEMBL: | CHEMBL2374220 |